On Monday, May 24th, Dr. Dana Goldman will moderate a panel at the 21st Annual International Meeting of ISPOR titled "Pharmaceutical pricing in the United States: Are we balancing innovation and affordability?" In addition to Dr. Goldman, the panel will include Dr. Tomas Philipson of the University of Chicago and Dr. Dan Ollendorf of the Institute for Clinical and Economic Review. Panelists will present viewpoints on the competing goals of increasing access to medicines and encouraging ongoing investment by innovators and discuss the potential benefits and pitfalls of policies designed to cap spending.Read more here.
Viewpoint 5/20/16Chandra and Shafrin Address Value Frameworks in JAMA
Amitabh Chandra, Jason Shafrin, and Ravider Dhawan examine the utility of cancer value frameworksREAD MORE
Event 5/20/16ISPOR 2016: Neumann to moderate issue panel on "What's next for value frameworks?"
Dr. Peter Neumann will moderate an issue panel at the ISPOR 21st Annual International Meeting this Monday, May 23rd, entitled "What's next for value frameworks for prescription drugs?"READ MORE